ALGERNON NEUROSCIENCE
Live / Registered — Registered (as of 15 Sept 2026)
What this means for you
Registered since 15 Sept 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98072604
- Registration number
- 8429204
- Mark type
- Stylized text
- Filed
- 06 Jul 2023
- Published for opposition
- 28 Jul 2026
- Registered
- 15 Sept 2026
- Attorney of record
- Lauren K. Tagarao
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for treatment in humans of brain injuries, namely, stroke and traumatic brain injury.
Owner
- Algernon Pharmaceuticals Inc., Vancouver, BC, CA
- Algernon Pharmaceuticals Inc., Vancouver, BC, CA
- Algernon Pharmaceuticals Inc., Vancouver, BC, CA
Prosecution history
- 15 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 28 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jul 2026 — PUBLISHED FOR OPPOSITION
- 22 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jun 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 24 Mar 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 24 Mar 2026 — LETTER OF SUSPENSION E-MAILED
- 24 Mar 2026 — SUSPENSION LETTER WRITTEN
- 24 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Mar 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 12 Jan 2026 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED